“…5 (a), the subpathways are up-regulated in the high-risk group. Interestingly, overexpression of CCNB1 , MYBL2 , and ESR1 , promoting cell proliferation, can lead to higher recurrence risks [39] , [45] . To further examine the prognostic potential of the top-3 subpathways, we conducted survival analyses and a simulation study assuming a targeted therapy situation.…”